Novartis plans to merge MorphoSys AG into Novartis BidCo Germany AG via a merger squeeze-out process.
MorphoSys AG announces that Novartis BidCo Germany AG intends to merge MorphoSys AG into Novartis BidCo Germany AG. Novartis submitted a formal request to initiate a merger squeeze-out process, aiming to transfer shares of MorphoSys AG's minority shareholders to Novartis BidCo Germany AG against adequate cash compensation. The procedure ensures a shareholders' resolution for the merger.
June 20, 2024
6 Articles